NR1H4 and Hepatic fibrosis: Exo‐OCAs prevent the activation of HSCs by promoting the expression of the farnesoid X receptor‒cytochrome P450 7A1 (FXR‐Cyp7a1) cascade to reduce liver fibrosis.